Managing Aerophagia with BiPAP
Switch to auto-BiPAP to reduce expiratory pressure while maintaining airway patency, as this resolves or significantly improves aerophagia symptoms in approximately 84% of patients. 1
Primary Management Strategy
The most effective approach is transitioning from CPAP to BiPAP (bilevel positive airway pressure) when aerophagia develops. Recent evidence demonstrates that BiPAP achieved excellent symptom resolution in 80.4% of patients with CPAP-related aerophagia, with an additional 4% showing partial improvement 1. The key mechanism is reducing the 90th percentile expiratory positive airway pressure (EPAP) compared to CPAP levels while maintaining adequate inspiratory pressure (IPAP) to keep the airway patent 1.
Specific Pressure Adjustment Protocol
- Target EPAP reduction: Lower the expiratory pressure below what was required with CPAP (typically the 90th-95th percentile pressure)
- Maintain adequate IPAP: Ensure inspiratory pressure is sufficient to eliminate obstructive events (apneas, hypopneas, RERAs, snoring) 2
- Critical threshold awareness: EPAP ≤ 6.5 cmH₂O may paradoxically cause aerophagia in some patients, likely due to upper esophageal sphincter relaxation 1
When BiPAP Fails or Is Insufficient
For the 15.7% of patients with poor BiPAP effectiveness 1:
- Reassess if symptoms truly worsened with PAP: Most patients reporting aerophagia with CPAP were already symptomatic before therapy initiation 3. Only flatulence shows consistent worsening with PAP therapy
- Consider alternative PAP interfaces: Proper mask fitting and type selection may reduce air leakage into the esophagus
- Implement behavioral modifications: Have patients sit upright for approximately 30 minutes after meals before using BiPAP, as supine positioning post-meal increases gastric insufflation risk 4
Important Clinical Caveats
Avoid premature therapy abandonment: Only 1% of patients discontinue CPAP due to aerophagia symptoms 3. Among patients with residual symptoms on BiPAP, 62.5% still reported reduced discomfort and satisfaction with the therapy 1. Visual analog scale scores for discomfort decreased significantly even in patients with incomplete resolution.
Pressure titration boundaries: Per AASM guidelines, if obstructive events persist at CPAP ≥15 cmH₂O, switching to BPAP is appropriate 2. Start with minimum IPAP of 8 cmH₂O and EPAP of 4 cmH₂O for adults 2.
Mechanism of Benefit
The therapeutic effect stems from lower expiratory pressure reducing inspiratory flow injection into the esophagus while the pressure differential between IPAP and EPAP maintains upper airway patency 1. This addresses the primary pathophysiology: pressurized air leaking into the stomach during the expiratory phase, causing belching, abdominal distention, and flatulence.